• Cristina Magi-Galluzzi, MD, PhD, was born in Ancona, Italy. From 2004 until 2018, she served as Director of Genitourinary Pathology in the Department of Pathology at Cleveland Clinic. She was also Professor of Pathology at the Lerner College of Medicine at Case Western Reserve University.

    She is board-certified in anatomic pathology with many clinical interests, including benign and pre-neoplastic (HGPIN) conditions of the prostate gland, prostate cancer, bladder and kidney cancer.

    Dr. Magi-Galluzzi has been invited to lecture at national and international medical meetings and has authored more than 80 scientific papers on genitourinary topics, including prostate cancer, neoadjuvant treatment for prostate cancer, incidence of HGPIN and subsequent cancer risk. She has authored or co-authored 6 books.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2022 A tribute to Prof. Ondrej Hes, MD, PhD (1968-2022)Modern Pathology.  35:2023-2024. 2022
    2022 Clinicopathologic and molecular spectrum of testicular sex cord-stromal tumors not amenable to specific histopathologic subclassificationModern Pathology.  35:1944-1954. 2022
    2022 Ensuring remote diagnostics for pathologists: an open letter to the US CongressNature Medicine.  28:2453-2455. 2022
    2022 Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: Guideline From the College of American Pathologists in Collaboration With the Association for Molecular Pathology and Fight Colorectal CancerArchives of Pathology and Laboratory Medicine.  146:1194-1210. 2022
    2022 Updates in 2022 on the staging of testicular germ cell tumorsHuman Pathology.  128:152-160. 2022
    2022 Pathological characterization and clinical outcome of penile intraepithelial neoplasia variants: a North American seriesModern Pathology.  35:1101-1109. 2022
    2022 Single- versus multi-port robotic partial nephrectomy: a comparative analysis of perioperative outcomes and analgesic requirementsJournal of Robotic Surgery.  16:695-703. 2022
    2022 Granulomas associated with renal neoplasms: A multi-institutional clinicopathological study of 111 casesHistopathology.  80:922-927. 2022
    2022 Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC/MTOR mutations: next-generation sequencing multi-institutional study of 19 casesModern Pathology.  35:344-351. 2022
    2022 Validating the association of adverse pathology with distant metastasis and prostate cancer mortality 20-years after radical prostatectomyUrologic Oncology: seminars and original investigations.  40:104.e1-104.e7. 2022
    2022 Correction to: Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases (Modern Pathology, (2021), 10.1038/s41379-021-00923-6)Modern Pathology.  35:289. 2022
    2022 Testicular Germ-Cell Tumors with Spermatic Cord Involvement: A Retrospective International Multi-Institutional ExperienceModern Pathology.  35:249-255. 2022
    2022 Reporting Trends, Practices, and Resource Utilization in Neuroendocrine Tumors of the Prostate Gland: A Survey among Thirty-Nine Genitourinary PathologistsInternational Journal of Surgical Pathology2022
    2021 Computer extracted gland features from H&E predicts prostate cancer recurrence comparably to a genomic companion diagnostic test: a large multi-site studynpj Precision Oncology.  5. 2021
    2021 Vascular architectural patterns in clear cell renal cell carcinoma and clear cell papillary renal cell carcinoma 2021
    2021 Diagnostic utility of one-stop fusion gene panel to detect TFE3/TFEB gene rearrangement and amplification in renal cell carcinomasModern Pathology.  34:2055-2063. 2021
    2021 What do we have to know about pd-l1 expression in prostate cancer? A systematic literature review. part 1: Focus on immunohistochemical results with discussion of pre-analytical and interpretation variablesCells.  10. 2021
    2021 What do we have to know about pd-l1 expression in prostate cancer? A systematic literature review. part 2: Clinic–pathologic correlationsCells.  10. 2021
    2021 New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasiaModern Pathology.  34:1392-1424. 2021
    2021 The Genitourinary Pathology Society Update on Classification and Grading of Flat and Papillary Urothelial Neoplasia with New Reporting Recommendations and Approach to Lesions with Mixed and Early Patterns of NeoplasiaAdvances in Anatomic Pathology.  28:179-195. 2021
    2021 The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial CancersAdvances in Anatomic Pathology.  28:196-208. 2021
    2021 Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasiaModern Pathology.  34:1167-1184. 2021
    2021 Correction to: Novel, emerging and provisional renal entities: the Genitourinary Pathology Society (GUPS) update on renal neoplasia (Modern Pathology, (2021), 10.1038/s41379-021-00737-6)Modern Pathology.  34:1037. 2021
    2021 Practice patterns related to prostate cancer grading: results of a 2019 Genitourinary Pathology Society clinician surveyUrologic Oncology: seminars and original investigations.  39:295.e1-295.e8. 2021
    2021 TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1Modern Pathology.  34:842-850. 2021
    2021 The 2019 genitourinary pathology society (GUPS) white paper on contemporary grading of prostate cancerArchives of Pathology and Laboratory Medicine.  145:461-493. 2021
    2021 Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologistsModern Pathology.  34:660-671. 2021
    2021 GPS Assay association with long-term cancer outcomes: Twenty-year risk of distant metastasis and prostate cancer-specific mortalityJCO Precision Oncology.  5:442-449. 2021
    2021 A novel imaging based Nomogram for predicting post-surgical biochemical recurrence and adverse pathology of prostate cancer from pre-operative bi-parametric MRIEBioMedicine.  63. 2021
    2021 Correction to: Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases (Modern Pathology, (2021), 10.1038/s41379-021-00923-6)Modern Pathology2021
    2021 Diagnosis of "cribriform" prostatic adenocarcinoma: an interobserver reproducibility study among urologic pathologists with recommendations.American Journal of Cancer Research.  11:3990-4001. 2021
    2020 ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217Modern Pathology.  33:2564-2579. 2020
    2020 Clinicopathologic Study of Gleason Pattern 5 Prostatic Adenocarcinoma with "Single-cell" Growth Reveals 2 Distinct Types, One with "Plasmacytoid" FeaturesAmerican Journal of Surgical Pathology.  44:1635-1642. 2020
    2020 Multicenter Multireader Evaluation of an Artificial Intelligence-Based Attention Mapping System for the Detection of Prostate Cancer with Multiparametric MRIAmerican Journal of Roentgenology.  215:903-912. 2020
    2020 Single-port robotic partial and radical nephrectomies for renal cortical tumors: initial clinical experienceJournal of Robotic Surgery.  14:773-780. 2020
    2020 Clinicopathologic features and outcomes of anterior-dominant prostate cancer: implications for diagnosis and treatmentProstate Cancer and Prostatic Diseases.  23:435-440. 2020
    2020 Perioperative Outcomes of Single vs Multi-Port Robotic Assisted Radical Prostatectomy: A Single Institutional ExperienceInvestigative urology.  204:490-495. 2020
    2020 Reply by AuthorsInvestigative urology.  204:495. 2020
    2020 Reporting practices and resource utilization in the era of intraductal carcinoma of the prostate: A survey of genitourinary subspecialistsAmerican Journal of Surgical Pathology.  44:673-680. 2020
    2020 Immunohistochemical staining patterns of Ki-67 and p53 in florid reactive urothelial atypia and urothelial carcinoma in situ demonstrate significant overlapHuman Pathology.  98:81-88. 2020
    2020 High-volume Concurrent Polypoid Ureteritis and Ureteritis Cystica Manifesting With Ureteral ObstructionUrology.  136:e7-e11. 2020
    2019 Association of mTOR Pathway Markers and Clinical Outcomes in Patients with Intermediate-/High-risk Prostate Cancer: Long-Term AnalysisClinical Genitourinary Cancer.  17:366-372. 2019
    2019 Impact of cribriform pattern and intraductal carcinoma on Gleason 7 prostate cancer treated with external beam radiotherapyInvestigative urology.  202:710-715. 2019
    2019 Correlation between MRI phenotypes and a genomic classifier of prostate cancer: preliminary findingsEuropean Radiology.  29:4861-4870. 2019
    2019 Fumarát hydratáza deficientní karcinom z renálních buněk a jemu podobný karcinom z renálních buněk: Komparativní studie 23 geneticky testovaných případ&#367Ceskoslovenska patologie.  55:244-249. 2019
    2019 Older Age at Diagnosis and Initial Disease Volume Predict Grade Reclassification Risk on Confirmatory Biopsy in Patients Considered for Active SurveillanceUrology.  130:106-112. 2019
    2019 Randomized phase II trial of neoadjuvant everolimus in patients with high-risk localized prostate cancerInvestigational New Drugs.  37:559-566. 2019
    2019 Protein Kinase N1 control of androgen-responsive serum response factor action provides rationale for novel prostate cancer treatment strategyOncogene.  38:4496-4511. 2019
    2019 Low Rate of Cancer Events After Partial Nephrectomy for Renal Cell Carcinoma: Clinicopathologic Analysis of 1994 Cases with Emphasis on Definition of “Recurrence”Clinical Genitourinary Cancer.  17:209-215.e1. 2019
    2019 Clinical significance and EZH2, ERG and SPINK1 protein expression in pure and mixed ductal adenocarcinoma of the prostate 2019
    2019 Fumarate hydratase deficient renal cell carcinoma: Chromosomal numerical aberration analysis of 12 casesAnnals of Diagnostic Pathology.  39:63-68. 2019
    2019 Fumarate hydratase deficient renal cell carcinoma and fumarate hydratase deficient-like renal cell carcinoma: Morphologic comparative study of 23 genetically tested cases.Ceskoslovenska patologie.  55:244-249. 2019
    2019 High-grade oncocytic tumour (HOT) of kidney in a patient with tuberous sclerosis complexHistopathology.  75:440-442. 2019
    2019 Transcriptomic and protein analysis of small-cell bladder cancer (SCBC) Identifies prognostic biomarkers and DLL3 as a relevant therapeutic targetClinical Cancer Research.  25:210-221. 2019
    2018 "atrophic Kidney"-like LesionAmerican Journal of Surgical Pathology.  42:1585-1595. 2018
    2018 Granular Cell Tumor of the Bladder: A Report of Six CasesUrology.  121:203.e1-203.e5. 2018
    2018 IFNL4-ΔG allele is associated with an interferon signature in tumors and survival of African-American men with prostate cancerClinical Cancer Research.  24:5471-5481. 2018
    2018 Immunohistochemical Pitfalls in Genitourinary Pathology: 2018 UpdateAdvances in Anatomic Pathology.  25:387-399. 2018
    2018 The 17-Gene Genomic Prostate Score Assay Predicts Outcome After Radical Prostatectomy Independent of PTEN StatusUrology.  121:132-138. 2018
    2018 Acquired cystic disease-associated renal cell carcinoma (ACD-RCC): A multiinstitutional study of 40 cases with clinical follow-upAmerican Journal of Surgical Pathology.  42:1156-1165. 2018
    2018 Can computer-aided diagnosis assist in the identification of prostate cancer on prostate MRI? A multi-center, multi-reader investigationOncotarget.  9:33804-33817. 2018
    2018 Unfavorable pathology, tissue biomarkers and genomic tests with clinical implications in prostate cancer managementAdvances in Anatomic Pathology.  25:293-303. 2018
    2018 Prognostic Factors and Risk Stratification in Invasive Upper Tract Urothelial CarcinomaClinical Genitourinary Cancer.  16:e751-e760. 2018
    2018 SWI/SNF protein expression status in fumarate hydratase–deficient renal cell carcinoma: immunohistochemical analysis of 32 tumors from 28 patientsHuman Pathology.  77:139-146. 2018
    2018 Utility of Pathology Imagebase for standardisation of prostate cancer gradingHistopathology.  73:8-18. 2018
    2018 Eosinophilic solid and cystic renal cell carcinomas have metastatic potentialHistopathology.  72:1066-1067. 2018
    2018 Features and Prognostic Significance of Intraductal Carcinoma of the Prostate 2018
    2018 Biphasic papillary renal cell carcinoma is a rare morphological variant with frequent multifocality: a study of 28 casesHistopathology.  72:777-785. 2018
    2018 Validation of GEMCaP as a DNA Based Biomarker to Predict Prostate Cancer Recurrence after Radical ProstatectomyInvestigative urology.  199:719-725. 2018
    2018 Genomic Scores are Independent of Disease Volume in Men with Favorable Risk Prostate Cancer: Implications for Choosing Men for Active SurveillanceInvestigative urology.  199:438-444. 2018
    2018 Impact of 5α-Reductase Inhibitors on Disease Reclassification among Men on Active Surveillance for Localized Prostate Cancer with Favorable FeaturesInvestigative urology.  199:445-452. 2018
    2018 Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: Systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assaysModern Pathology.  31:179-197. 2018
    2018 PTEN Expression in Mucinous Prostatic Adenocarcinoma, Prostatic Adenocarcinoma with Mucinous Features, and Adjacent Conventional Prostatic Adenocarcinoma: A Multi-institutional Study of 92 CasesApplied Immunohistochemistry and Molecular Morphology.  26:225-230. 2018
    2018 Prostate cancer: diagnostic criteria and role of immunohistochemistryModern Pathology.  31:12-21. 2018
    2018 Reappraisal of Morphologic Differences between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell CarcinomaAmerican Journal of Surgical Pathology.  42:279-292. 2018
    2017 Erratum: Correction: A comprehensive analysis of coregulator recruitment, androgen receptor function and gene expression in prostate cancer (eLife (2017) 6 PII: e33738)eLife.  6. 2017
    2017 Pathology Imagebase—a reference image database for standardization of pathologyHistopathology.  71:677-685. 2017
    2017 Direct metabolic interrogation of dihydrotestosterone biosynthesis from adrenal precursors in primary prostatectomy tissuesClinical Cancer Research.  23:6351-6363. 2017
    2017 A comprehensive analysis of coregulator recruitment, androgen receptor function and gene expression in prostate cancereLife.  6. 2017
    2017 Programmed death-1 (PD-1) receptor/PD-1 ligand (PD-L1) expression in fumarate hydratase-deficient renal cell carcinomaAnnals of Diagnostic Pathology.  29:17-22. 2017
    2017 Reporting and staging of testicular germ cell tumors: The international society of urological pathology (ISUP) testicular cancer consultation conference recommendationsAmerican Journal of Surgical Pathology.  41:e22-e32. 2017
    2017 Targeted Contrast Agent Specific to an Oncoprotein in Tumor Microenvironment with the Potential for Detection and Risk Stratification of Prostate Cancer with MRIBioconjugate Chemistry.  28:1031-1040. 2017
    2017 Squamous cell carcinoma of the bladder complicating schistosomiasis 2017
    2017 The World Health Organization 2016 classification of testicular non-germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation PanelHistopathology.  70:513-521. 2017
    2017 Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancereLife.  6. 2017
    2017 The World Health Organization 2016 classification of testicular germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation PanelHistopathology.  70:335-346. 2017
    2017 Robot-assisted ureteral reconstruction using a tubularized peritoneal flap: a novel technique in a chronic porcine modelWorld Journal of Urology.  35:89-96. 2017
    2017 Small cell-like glandular proliferation of prostate: a rare lesion not related to small cell prostate cancer 2017
    2017 Upper tract urothelial carcinomas: Frequency of association with mismatch repair protein loss and lynch syndromeModern Pathology.  30:146-156. 2017
    2016 HSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort study 2016
    2016 Tubulocystic carcinoma of the kidney with poorly differentiated fociAmerican Journal of Surgical Pathology.  40:1457-1472. 2016
    2016 Contemporary Gleason grading and novel Grade Groups in clinical practiceCurrent Opinion in Urology.  26:488-492. 2016
    2016 Gleason grade 4 prostate adenocarcinoma patterns: an interobserver agreement study among genitourinary pathologistsHistopathology.  69:441-449. 2016
    2016 Tumor Necrosis Adds Prognostically Significant Information to Grade in Clear Cell Renal Cell Carcinoma: A Study of 842 Consecutive Cases from a Single InstitutionAmerican Journal of Surgical Pathology.  40:1224-1231. 2016
    2016 PTEN Expression in Mucinous Prostatic Adenocarcinoma, Prostatic Adenocarcinoma With Mucinous Features, and Adjacent Conventional Prostatic Adenocarcinoma: A Multiinstitutional Study of 92 Cases.Applied Immunohistochemistry and Molecular Morphology2016
    2016 Gene expression in normal-appearing tissue adjacent to prostate cancers are predictive of clinical outcome: Evidence for a biologically meaningful field effectOncotarget.  7:33855-33865. 2016
    2016 Malakoplakia associated with prostatic adenocarcinoma Report of 4 cases and literature reviewAnnals of Diagnostic Pathology.  22:33-37. 2016
    2016 Collecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulationOncotarget.  7:29901-29915. 2016
    2016 Tissue Effects in a Randomized Controlled Trial of Short-term Finasteride in Early Prostate CancerEBioMedicine.  7:85-93. 2016
    2016 Decipher Genomic Classifier Measured on Prostate Biopsy Predicts Metastasis RiskUrology.  90:148-152. 2016
    2016 A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason ScoreEuropean Urology.  69:428-435. 2016
    2016 Eosinophilic, solid, and cystic renal cell carcinomaAmerican Journal of Surgical Pathology.  40:60-71. 2016
    2016 Fumarate hydratase-deficient renal cell carcinoma is strongly correlated with fumarate hydratase mutation and hereditary leiomyomatosis and renal cell carcinoma syndromeAmerican Journal of Surgical Pathology.  40:865-875. 2016
    2016 Renal cell carcinoma occurring in patients with prior neuroblastomaAmerican Journal of Surgical Pathology.  40:989-997. 2016
    2016 Renal neoplasms with overlapping features of clear cell renal cell carcinoma and clear cell papillary renal cell carcinoma a clinicopathologic study of 37 cases from a single institutionAmerican Journal of Surgical Pathology.  40:141-154. 2016
    2015 MicroRNA in prostate cancer: Practical aspects 2015
    2015 Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypesEuropean Urology.  68:555-567. 2015
    2015 Diagnosis of "poorly formed glands" Gleason pattern 4 prostatic adenocarcinoma on needle biopsy: An interobserver reproducibility study among urologic pathologists with recommendationsAmerican Journal of Surgical Pathology.  39:1331-1339. 2015
    2015 Handling and reporting of orchidectomy specimens with testicular cancer: Areas of consensus and variation among 25 experts and 225 European pathologistsHistopathology.  67:313-324. 2015
    2015 Novel biomarkers and genomic tests in prostate cancer: A critical analysisMinerva Urologica e Nefrologica.  67:211-231. 2015
    2015 Does cumulative prostate cancer length (CCL) in prostate biopsies improve prediction of clinically insignificant cancer at radical prostatectomy in patients eligible for active surveillance?BJU International.  116:220-229. 2015
    2015 The TMPRSS2-ERG gene fusion blocks XRCC4-mediated nonhomologous end-joining repair and radiosensitizes prostate cancer cells to PARP inhibitionMolecular Cancer Therapeutics.  14:1896-1906. 2015
    2015 Biology of Human Tumors Development and clinical validation of an in situ biopsy-based multimarker assay for risk stratification in prostate cancerClinical Cancer Research.  21:2591-2600. 2015
    2015 EDB fibronectin specific peptide for prostate cancer targetingBioconjugate Chemistry.  26:830-838. 2015
    2015 Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancerModern Pathology.  28:612-630. 2015
    2015 A genomic algorithm for the molecular classification of common renal cortical neoplasms: Development and validationInvestigative urology.  193:1479-1485. 2015
    2015 Metastatic prostate adenocarcinoma to the penis presenting as pagetoid carcinomaAmerican Journal of Surgical Pathology.  39:724-726. 2015
    2015 A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapyEuropean Urology.  67:778-786. 2015
    2015 Renal leiomyoma: A contemporary multi-institution study of an infrequent and frequently misclassified neoplasmAmerican Journal of Surgical Pathology.  39:349-356. 2015
    2015 Utility of PTEN and ERG immunostaining for distinguishing high-grade PIN from Intraductal Carcinoma of the Prostate on Needle BiopsyAmerican Journal of Surgical Pathology.  39:169-178. 2015
    2015 Methylome-wide Sequencing Detects DNA Hypermethylation Distinguishing Indolent from Aggressive Prostate CancerCell Reports.  13:2135-2146. 2015
    2015 Upper tract urinary cytology to detect upper tract urothelial carcinoma: Using the Johns Hopkins Hospital template and evaluation of its feasibilityCytoJournal.  12. 2015
    2015 Urinary bladder xanthoma: A multi-institutional series of 17 casesHistopathology.  67:255-261. 2015
    2014 Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsiesInvestigative urology.  192:1081-1087. 2014
    2014 Autophagic flux determines cell death and survival in response to Apo2L/TRAIL (dulanermin)Molecular Cancer.  13. 2014
    2014 A 17-gene assay to predict prostate cancer aggressiveness in the context of gleason grade heterogeneity, tumor multifocality, and biopsy undersamplingEuropean Urology.  66:550-560. 2014
    2014 Diagnostic criteria for ductal adenocarcinoma of the prostate: Interobserver variability among 20 expert uropathologistsHistopathology.  65:216-227. 2014
    2014 Epithelial-to-mesenchymal transition in renal neoplasmsAdvances in Anatomic Pathology.  21:174-180. 2014
    2014 Intraductal carcinoma of the prostate: Interobserver reproducibility survey of 39 urologic pathologistsAnnals of Diagnostic Pathology.  18:333-342. 2014
    2014 RNA biomarkers associated with metastatic progression in prostate cancer: A multi-institutional high-throughput analysis of SChLAP1 2014
    2014 Renal tumors: The International Society of Urologic Pathology (ISUP) 2012 consensus conference recommendationsAnnales de Pathologie.  34:448-461. 2014
    2014 Rhabdoid differentiation is associated with aggressive behavior in renal cell carcinoma: A clinicopathologic analysis of 76 cases with clinical follow-upAmerican Journal of Surgical Pathology.  38:1260-1265. 2014
    2014 Succinate dehydrogenase (SDH)-deficient renal carcinoma: A morphologically distinct entity: A clinicopathologic series of 36 tumors from 27 patientsAmerican Journal of Surgical Pathology.  38:1588-1602. 2014
    2014 Tuberous sclerosis-associated renal cell carcinoma: A clinicopathologic study of 57 separate carcinomas in 18 patientsAmerican Journal of Surgical Pathology.  38:1457-1467. 2014
    2013 ERG protein expression as a biomarker of prostate cancerBiomarkers in Medicine.  7:851-865. 2013
    2013 Prediction of prostate cancer to urethra distance by a pretreatment nomogram: Urethral thermoprotection implication in cryoablationProstate Cancer and Prostatic Diseases.  16:372-375. 2013
    2013 Analytical validation of the Oncotype DX prostate cancer assay - a clinical RT-PCR assay optimized for prostate needle biopsiesBMC Genomics.  14. 2013
    2013 Incidence and clinicopathological characteristics of intraductal carcinoma detected in prostate biopsies: A prospective cohort studyHistopathology.  63:574-579. 2013
    2013 Hereditary syndromes with associated renal neoplasia: A practical guide to histologic recognition in renal tumor resection specimensAdvances in Anatomic Pathology.  20:245-263. 2013
    2013 Prostate cancer patients older than 70 years treated by radical prostatectomy have higher biochemical recurrence rate than their matched younger counterpart 2013
    2013 Metanephric adenoma and solid variant of papillary renal cell carcinoma: Common and distinctive featuresHistopathology.  62:941-953. 2013
    2013 A 45-year-old with neuroendocrine carcinoma of the prostateUrology.  81:714-716. 2013
    2013 Intraductal carcinoma of the prostate: Precursor or aggressive phenotype of prostate cancer? 2013
    2013 Dysregulation of cholesterol homeostasis in human prostate cancer through loss of ABCA1Cancer Research.  73:1211-1218. 2013
    2013 Handling and staging of renal cell carcinoma: The International Society of Urological Pathology Consensus (ISUP) conference recommendationsAmerican Journal of Surgical Pathology.  37:1505-1517. 2013
    2013 Metastatic papillary thyroid carcinoma to the kidney: Report of two cases mimicking primary renal cell carcinoma and review of the literaturePathology.  45:89-93. 2013
    2013 Renal tumors: Diagnostic and prognostic biomarkersAmerican Journal of Surgical Pathology.  37:1518-1531. 2013
    2013 Robotic real-time near infrared targeted fluorescence imaging in a murine model of prostate cancer: A feasibility studyUrology.  81:451-457. 2013
    2013 The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasiaAmerican Journal of Surgical Pathology.  37:1469-1489. 2013
    2013 The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parametersAmerican Journal of Surgical Pathology.  37:1490-1504. 2013
    2012 EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-IndependentScience.  338:1465-1469. 2012
    2012 ERG protein expression in human tumors detected with a rabbit monoclonal antibodyAmerican Journal of Clinical Pathology.  138:803-810. 2012
    2012 Expression of ERG protein, a prostate cancer specific marker, in high grade prostatic intraepithelial neoplasia (HGPIN): Lack of utility to stratify cancer risks associated with HGPINBJU International.  110. 2012
    2012 Discrepancy in prostate cancer localization between biopsy and prostatectomy specimens in patients with unilateral positive biopsy: Implications for focal therapy 2012
    2012 A contemporary update on pathology reporting for prostate cancer: Biopsy and radical prostatectomy specimensEuropean Urology.  62:20-39. 2012
    2012 High-Grade prostatic intraepithelial neoplasiaInvestigative and Clinical Urology.  53:297-303. 2012
    2012 Intraductal carcinoma of the prostateArchives of Pathology and Laboratory Medicine.  136:418-425. 2012
    2011 Folate hydrolase (prostate-specific antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculatureModern Pathology.  24:1521-1529. 2011
    2011 ERG gene rearrangement status in prostate cancer detected by immunohistochemistry 2011
    2011 PAX8 and PAX2 immunostaining facilitates the diagnosis of primary epithelial neoplasms of the male genital tractAmerican Journal of Surgical Pathology.  35:1473-1483. 2011
    2011 Grading of clear cell renal cell carcinoma should be based on nucleolar prominenceAmerican Journal of Surgical Pathology.  35:1134-1139. 2011
    2011 International society of urological pathology consensus conference on handling and staging of radical prostatectomy specimensAdvances in Anatomic Pathology.  18:301-305. 2011
    2011 The utility of ERG/P63 double immunohistochemical staining in the diagnosis of limited cancer in prostate needle biopsiesAmerican Journal of Surgical Pathology.  35:1062-1068. 2011
    2011 TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of Caucasian, African-American and Japanese patients 2011
    2011 The diagnostic utility of novel immunohistochemical marker ERG in the workup of prostate biopsies with "atypical glands suspicious for cancer"American Journal of Surgical Pathology.  35:608-614. 2011
    2011 Prostate cancer staging and grading at radical prostatectomy over timeAdvances in Anatomic Pathology.  18:159-164. 2011
    2011 Single focus prostate cancer: Pathological features and erg fusion statusInvestigative urology.  185:489-494. 2011
    2011 Adenomatoid tumour of the adrenal gland in a patient with germline SDHD mutation: A case report and review of the literaturePathology.  43:495-498. 2011
    2011 International society of urological pathology (ISUP) consensus conference on handling and staging of radical prostatectomy specimens. working group 3: Extraprostatic extension, lymphovascular invasion and locally advanced diseaseModern Pathology.  24:26-38. 2011
    2011 Pathology update for urologists.Prostate Cancer.  2011:183761. 2011
    2011 The Epstein criteria predict for organ-confined but not insignificant disease and a high likelihood of cure at radical prostatectomyInternational Brazilian Journal of Urology.  37:123. 2011
    2010 Clear cell tubulopapillary renal cell carcinoma: A study of 36 distinctive low-grade epithelial tumors of the kidneyAmerican Journal of Surgical Pathology.  34:1608-1621. 2010
    2010 ERG rearrangement is present in a subset of transition zone prostatic tumorsModern Pathology.  23:1499-1506. 2010
    2010 Multifocal high grade prostatic intraepithelial neoplasia is a risk factor for subsequent prostate cancerInvestigative urology.  184:1958-1962. 2010
    2010 Renal cell carcinomas with intratumoral fat and concomitant angiomyolipoma: Potential pitfalls in staging and diagnosisAmerican Journal of Clinical Pathology.  134:807-812. 2010
    2010 Can saturation biopsy predict prostate cancer localization in radical prostatectomy specimens: A correlative study and implications for focal therapyUrology.  76:682-687. 2010
    2010 ReplyUrology.  76:687-688. 2010
    2010 Staging prostate cancer and its relationship to prognosisCurrent Diagnostic Pathology.  16:432-438. 2010
    2010 The Epstein Criteria Predict for Organ-Confined But Not Insignificant Disease and a High Likelihood of Cure at Radical ProstatectomyEuropean Urology.  58:90-95. 2010
    2010 Importance of Additional "Extreme" Anterior Apical Needle Biopsies in the Initial Detection of Prostate CancerUrology.  75:1034-1039. 2010
    2010 Atypical cribriform lesions of the prostate: Relationship to prostatic carcinoma and implication for diagnosis in prostate biopsiesAmerican Journal of Surgical Pathology.  34:470-477. 2010
    2010 ETS gene aberrations in atypical cribriform lesions of the prostate: Implications for the distinction between intraductal carcinoma of the prostate and cribriform high-grade prostatic intraepithelial neoplasiaAmerican Journal of Surgical Pathology.  34:478-485. 2010
    2010 Third prize: Synchronized real-time ultrasonography and three-dimensional computed tomography scan navigation during percutaneous renal cryoablation in a porcine model 2010
    2010 Ductal adenocarcinoma of the prostate diagnosed on transurethral biopsy or resection is not always indicative of aggressive disease: Implications for clinical managementBJU International.  105:476-480. 2010
    2010 Clinicopathological features of prostate cancers detected after an initial diagnosis of 'atypical glands suspicious for cancer'Pathology.  42:334-338. 2010
    2010 Editorial CommentInvestigative urology.  183:157. 2010
    2009 Are prostate needle biopsies predictive of the laterality of significant cancer and positive surgical margins?BJU International.  104:1599-1603. 2009
    2009 Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: Implications for pathologic classificationAmerican Journal of Surgical Pathology.  33:1840-1849. 2009
    2009 KTP Laser Nerve Sparing Radical Prostatectomy: Comparison of Ultrasonic and Cold Scissor Dissection on Cavernous Nerve FunctionInvestigative urology.  181:2760-2766. 2009
    2009 Phase II Trial of Neoadjuvant Nab-Paclitaxel in High Risk Patients With Prostate Cancer Undergoing Radical ProstatectomyInvestigative urology.  181:1672-1677. 2009
    2009 Renal angiomyolipoma: Clinicopathologic study of 194 cases with emphasis on the epithelioid histology and tuberous sclerosis associationAmerican Journal of Surgical Pathology.  33:289-297. 2009
    2009 Adult cystic nephroma and mixed epithelial and stromal tumor of the kidney are the same disease entity: Molecular and histologic evidenceAmerican Journal of Surgical Pathology.  33:72-80. 2009
    2009 Microscopic bladder neck involvement by prostate carcinoma in radical prostatectomy specimens is not a significant independent prognostic factorModern Pathology.  22:385-392. 2009
    2008 Low Testosterone and Risk of Biochemical Recurrence and Poorly Differentiated Prostate Cancer at Radical ProstatectomyUrology.  72:1240-1245. 2008
    2008 Prostatic Adenocarcinoma, Prostatic Intraepithelial Neoplasia, and Intraductal CarcinomaSurgical Pathology Clinics.  1:43-75. 2008
    2008 Urothelial Carcinoma and its VariantsSurgical Pathology Clinics.  1:159-209. 2008
    2008 Pathologic characteristics of solitary small renal masses: Can they be predicted by preoperative clinical parameters?American Journal of Clinical Pathology.  130:560-564. 2008
    2008 Laser robotically assisted nerve-sparing radical prostatectomy: A pilot study of technical feasibility in the canine modelBJU International.  102:598-602. 2008
    2008 The distinction of bronchogenic cyst from metastatic testicular teratoma: A light microscopic and immunohistochemical studyAmerican Journal of Clinical Pathology.  130:265-273. 2008
    2008 Adult Cystic Nephroma and Mixed Epithelial and Stromal Tumor of the Kidney: Clinical, Radiographic, and Pathologic CharacteristicsUrology.  71:1142-1148. 2008
    2008 Clinical and biological effects of neoadjuvant sargramostim and thalidomide in patients with locally advanced prostate carcinomaClinical Cancer Research.  14:3052-3059. 2008
    2008 Saturation Technique Does Not Decrease Cancer Detection During Followup After Initial Prostate BiopsyInvestigative urology.  179:1746-1750. 2008
    2008 Pathological Aggressiveness of Prostatic Carcinomas Related to RNASEL R462Q Allelic VariantsInvestigative urology.  179:1344-1348. 2008
    2008 Renal cell carcinomas with papillaeRevista Española de Patología.  41:99-107. 2008
    2008 Prostate Cancer Volume at Biopsy Predicts Clinically Significant UpgradingInvestigative urology.  179:896-900. 2008
    2007 Parasagittal biopsies are more important as part of an initial biopsy strategy than as part of a repeat biopsy strategy: Observations from a unique populationProstate Cancer and Prostatic Diseases.  10:352-355. 2007
    2007 Pathological evidence of necrosis in recurrent renal mass following treatment with sunitinibInternational Journal of Urology.  14:1095-1097. 2007
    2007 Pathologic Stage Migration Has Slowed in the Late PSA EraUrology.  70:839-842. 2007
    2007 Renal neuroendocrine tumours: A clinicopathological studyBJU International.  100:1030-1035. 2007
    2007 Preoperative PSA Is Still Predictive of Cancer Volume and Grade in Late PSA EraUrology.  70:711-716. 2007
    2007 Neoadjuvant docetaxel treatment for locally advanced prostate cancer: A clinicopathologic studyCancer.  110:1248-1254. 2007
    2007 Tumor Volume Does Not Predict for Biochemical Recurrence After Radical Prostatectomy in Patients with Surgical Gleason Score 6 or Less Prostate CancerUrology.  70:294-298. 2007
    2007 Erratum: A working group classification of focal prostate atrophy lesions (American Journal of Surgical Pathology (2006) 30, (1281-1291))American Journal of Surgical Pathology.  31:652. 2007
    2007 The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancerBJU International.  99:770-774. 2007
    2007 Differential expression of melanocytic markers in myoid, lipomatous, and vascular components of renal angiomyolipomasArchives of Pathology and Laboratory Medicine.  131:122-125. 2007
    2007 The prognostic significance of epidermal growth factor receptor expression in clear-cell renal cell carcinoma: A call for standardized methods for immunohistochemical evaluationClinical Genitourinary Cancer.  5:264-270. 2007
    2006 Erratum: A working group classification of focal prostate atrophy lesions (American Journal of Surgical Pathology (2006) 30 (1281-1291))American Journal of Surgical Pathology.  30:1489. 2006
    2006 A working group classification of focal prostate atrophy lesionsAmerican Journal of Surgical Pathology.  30:1281-1291. 2006
    2006 Mucinous adenocarcinoma of the prostate does not confer poor prognosisUrology.  68:825-830. 2006
    2006 Prostate basal cell lesions can be negative for basal cell keratins: A diagnostic pitfallCellular Oncology.  28:125-129. 2006
    2006 Real-time transrectal ultrasound guidance during laparoscopic radical prostatectomy: Impact on surgical marginsInvestigative urology.  175:1304-1310. 2006
    2006 Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variantPLoS Pathogens.  2:0211-0225. 2006
    2006 Peritumoral lymphatic invasion is associated with regional lymph node metastases in prostate adenocarcinomaModern Pathology.  19:392-398. 2006
    2006 Saturation technique does not improve cancer detection as an initial prostate biopsy strategyInvestigative urology.  175:485-488. 2006
    2006 Non-small cell lung carcinoma metastatic to the kidney. 2006
    2005 Laparoscopic partial nephrectomy for cystic massesInvestigative urology.  174:614-619. 2005
    2005 Local recurrence of prostate cancer in rectal submucosa after transrectal needle biopsy and radical prostatectomyUrology.  66:881.e7-881.e9. 2005
    2005 Potassium-titanyl-phosphate laser laparoscopic partial nephrectomy without hilar clamping in the survival calf modelInvestigative urology.  174:1110-1114. 2005
    2005 The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasmsClinics in Laboratory Medicine.  25:247-257. 2005
    2005 Water jet assisted laparoscopic partial nephrectomy without hilar clamping in the calf modelInvestigative urology.  174:317-321. 2005
    2004 ALK-1 expression in inflammatory myofibroblastic tumor of the urinary bladderAmerican Journal of Surgical Pathology.  28:1609-1614. 2004
    2004 Urothelial papilloma of the bladder: A review of 34 de novo casesAmerican Journal of Surgical Pathology.  28:1615-1620. 2004
    2004 Laparoscopic extended pelvic lymphadenectomy for bladder cancer: technique and initial outcomes. 2004
    2004 Continuing trends in pathological stage migration in radical prostatectomy specimensUrologic Oncology: seminars and original investigations.  22:300-306. 2004
    2004 Phase II trial of neoadjuvant docetaxel before radical prostatectomy for locally advanced prostate cancerUrology.  63:1138-1142. 2004
    2004 The Prognostic Significance of Tertiary Gleason Pattern 5 in Radical Prostatectomy SpecimensAmerican Journal of Surgical Pathology.  28:394-398. 2004
    2004 Laparoscopic extended pelvic lymphadenectomy for bladder cancer: Technique and initial outcomesInvestigative urology.  172:1809-1812. 2004
    2003 Alpha-methylacyl-CoA racemase: a variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy.American Journal of Surgical Pathology.  27:1128-1133. 2003
    2003 α-methylacyl-CoA racemase: A variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsyAmerican Journal of Surgical Pathology.  27:1128-1133. 2003
    2003 Atypia in nonneoplastic prostate glands after radiotherapy for prostate cancer: Duration of atypia and relation to type of radiotherapyAmerican Journal of Surgical Pathology.  27:206-212. 2003
    2003 Threshold for Diagnosing Prostate Cancer over TimeHuman Pathology.  34:1116-1118. 2003
    2002 Predictors of lymph node metastasis in T1 breast carcinoma, stratified by patient age 2002
    1999 Demonstrability of the glycoprotein A-80 in postradiation prostatic carcinomaHuman Pathology.  30:1474-1478. 1999
    1998 Mitogen-activated protein kinases and apoptosis in PIN 1998
    1998 Automated in situ hybridization: Diagnostic and research applicationsApplied Immunohistochemistry and Molecular Morphology.  7:69-75. 1998
    1997 Heterogeneity of androgen receptor content in advanced prostate cancerModern Pathology.  10:839-845. 1997
    1997 The cell cycle inhibitor p27 is an independent prognostic marker in small (T(1a,b)) invasive breast carcinomasCancer Research.  57:1259-1263. 1997
    1997 Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosisLaboratory Investigation.  76:37-51. 1997
    1996 Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesisAmerican Journal of Pathology.  149:1553-1564. 1996
    1996 Effect of microwave oven heating times on androgen receptor antigen retrieval from paraffin-embedded prostatic adenocarcinoma 1996
    1996 Mitogen-activated protein kinase and mitogen-activated kinase phosphatase-1 expression in the noble rat model of sex hormone-induced prostatic dysplasia and carcinomaLaboratory Investigation.  75:361-370. 1996
    1996 Immunohistochemical evaluation of type IV collagenase (72-kd metalloproteinase) in prostatic intraepithelial neoplasia 1996
    1996 Effect of microwave oven heating times on androgen receptor antigen retrieval from paraffin-embedded prostatic adenocarcinoma. 1996
    1996 Molecular events in the early phases of prostate carcinogenesisEuropean Urology.  30:167-176. 1996
    1995 Apoptotic Bodies in Prostatic Intraepithelial Neoplasia and Prostatic Adenocarcinoma Following Total Androgen Ablation 1995
    1994 Effects of combination endocrine treatment on normal prostate, prostatic intraepithelial neoplasia, and prostatic adenocarcinoma 1994
    1994 Morphometrically assisted grading of astrocytomasCellular Oncology.  16:351-356. 1994
    1994 Quantitative evaluation of nucleolar features on cytologic material in brain tumor diagnosisClinical Neuropathology.  13:323-328. 1994
    1993 Frequency and location of mitoses in prostatic intraepithelial neoplasia (PIN) 1993
    1993 Occurrence of cell death (apoptosis) in prostatic intra-epithelial neoplasiaVirchows Archiv. A, Pathological anatomy and histopathology.  423:351-357. 1993
    1993 Prostatic intra-epithelial neoplasia: Expression and location of proliferating cell nuclear antigen in epithelial, endothelial and stromal nucleiVirchows Archiv. A, Pathological anatomy and histopathology.  422:185-192. 1993
    1993 Computed cell cycle and DNA histogram analyses in image cytometry in breast cancer 1993
    1993 Proliferating Cell Nuclear Antigen (PCNA) evaluation in the diagnostic quantitative pathology of cribriform adenocarcinoma of the prostate 1993
    1993 Proliferating cell nuclear antigen (PCNA) in prostatic invasive adenocarcinoma. Is the proliferation state in the marginal zone of the tumour higher than in the central part? 1993
    1993 Prostatic Intra-epithelial Neoplasia: Qualitative and Quantitative Analyses of the Blood Capillary Architecture on Thin Tissue Sections 1993
    1993 Prostatic Invasive Adenocarcinoma: Effect of Combination Endocrine Therapy (LHRH Agonist and Flutamide) on the Expression and Location of Proliferating Cell Nuclear Antigen (PCNA) 1993
    1992 Aneuploidy and nuclear features of prostatic intraepithelial neoplasia (PIN)Journal of Cellular Biochemistry.  50:47-53. 1992
    1992 Quantitative analysis of quadriceps muscle biopsy in systemic sclerosis 1992
    1991 Quantitative analysis of nucleolar margination in diagnostic cytopathologyVirchows Archiv. A, Pathological anatomy and histopathology.  419:505-512. 1991


    Year Title Altmetric
    2015 Genitourinary pathology: Practical advances 2015
    2015 Preface 2015
    2015 Preface 2015
    2015 Preface 2015


    Year Title Altmetric
    2022 Chapter 10 Ureter, Urinary Bladder, and Kidney.  487-564. 2022
    2021 Ureter, Urinary Bladder, and Kidney.  487-564. 2021
    2015 Nonneoplastic diseases of the testis 2015
    2015 Classification of testicular tumors.  447-461. 2015
    2015 Contemporary prostate cancer staging.  33-44. 2015
    2015 Familial syndromes associated with testicular tumors.  491-499. 2015
    2015 Genetic and epigenetic alterations in testicular tumors.  521-527. 2015
    2015 Genetic determinants of familial and hereditary prostate cancer.  113-122. 2015
    2015 Management implications associated with unusual morphologic entities of the prostate.  79-91. 2015
    2015 Unusual epithelial and nonepithelial neoplasms of the prostate.  65-77. 2015
    2014 Ureter, Urinary Bladder, and Kidney.  460-533. 2014
    2013 Adenocarcinoma of the prostate 2013
    2013 Current issues in pathologic evaluation.  153-176. 2013
    2010 Ureter, urinary bladder, and kidney.  487-538. 2010
    2010 10 Ureter, Urinary Bladder, and Kidney.  487-538. 2010
    2009 Molecular Genitourinary Pathology.  379-392. 2009
    2009 Ureter, Urinary Bladder, and Kidney.  487-538. 2009
    2009 Chapter 28 Molecular Genitourinary Pathology.  379-392. 2009
    2008 Molecular Genitourinary Pathology.  379-392. 2008

    Research Overview

  • Bladder Cancer
    Enlarged Prostate/Benign Prostatic Hyperplasia
    Kidney Cancer
    Kidney Cysts, Simple
    Penile Cancer
    Prostate Cancer
    Prostate Disease
    Testicular Cancer
  • Education And Training

  • Doctor of Philosophy in Medical Pathology, University of Verona 1996
  • Doctor of Science in Medicine, 1990
  • Full Name

  • Cristina Magi-Galluzzi